Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentazocine for Manic Symptoms in Bipolar Disorder
NCT00125931Phase 2Completed
- Sponsor
- McLean Hospital
- Start
- Sep 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of pentazocine in bipolar disorder (BD), sponsored by McLean Hospital. Primary endpoint: Mania Acute Change Scale. Started Sep 2005; status: completed.
02
Drugs
pentazocine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00125931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125931.